Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Artesunate
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : Laser Surgery Care | Anal Dysplasia Clinic MidWest
Deal Size : Inapplicable
Deal Type : Inapplicable
Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
Details : Artesunate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Anal Squamous Intraepithelial Lesions.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 16, 2024
Lead Product(s) : Artesunate
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : Laser Surgery Care | Anal Dysplasia Clinic MidWest
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Artesunate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Cleveland Clinic
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Artesunate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Vulvar Diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 10, 2023
Lead Product(s) : Artesunate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Cleveland Clinic
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Artesunate
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : Amarex Clinical Research | University of California, San Francisco | Anal Dysplasia Clinic MidWest | Laser Surgery Care
Deal Size : Inapplicable
Deal Type : Inapplicable
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
Details : Artesunate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Anal Squamous Intraepithelial Lesions.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 27, 2022
Lead Product(s) : Artesunate
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : Amarex Clinical Research | University of California, San Francisco | Anal Dysplasia Clinic MidWest | Laser Surgery Care
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Artesunate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Amarex Clinical Research | MD Anderson Cancer Center | Harris Health System | Cleveland Clinic | University of Michigan | Morehouse School of Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
Details : Artesunate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Papillomavirus Infections.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 23, 2019
Lead Product(s) : Artesunate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Amarex Clinical Research | MD Anderson Cancer Center | Harris Health System | Cleveland Clinic | University of Michigan | Morehouse School of Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable